SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?


To: Intrepid1 who wrote (1063)4/15/1999 1:17:00 AM
From: Wisee  Read Replies (1) | Respond to of 1185
 
etc.

I don't think Golden Capital dropped NRT from it's buy recommendation.
Their latest report dated April/99, shows NRT with the highest score of 75.

I think Hoffman has got an extension for a couple of months. This is good news, because if they didn't like NRT's science (drug molecules) then they would have cancelled the deal back in March.

Wisee